272 related articles for article (PubMed ID: 10373066)
1. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
Nagler RM; Nagler A
Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
[TBL] [Abstract][Full Text] [Related]
2. Effect of pilocarpine hydrochloride on unstimulated whole saliva flow rate and composition in patients with chronic graft-versus-host disease (cGVHD).
Agha-Hosseini F; Mirzaii-Dizgah I; Ghavamzadeh L; Ghavamzadeh A; Tohidast-Acrad Z
Bone Marrow Transplant; 2007 Apr; 39(7):431-4. PubMed ID: 17310130
[TBL] [Abstract][Full Text] [Related]
3. Parotid salivary gland dysfunction in chronic graft-versus-host disease (cGVHD): a longitudinal study in a mouse model.
Levy S; Nagler A; Okon S; Marmary Y
Bone Marrow Transplant; 2000 May; 25(10):1073-8. PubMed ID: 10828868
[TBL] [Abstract][Full Text] [Related]
4. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).
Fox PC; Atkinson JC; Macynski AA; Wolff A; Kung DS; Valdez IH; Jackson W; Delapenha RA; Shiroky J; Baum BJ
Arch Intern Med; 1991 Jun; 151(6):1149-52. PubMed ID: 2043017
[TBL] [Abstract][Full Text] [Related]
5. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
[TBL] [Abstract][Full Text] [Related]
6. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
[TBL] [Abstract][Full Text] [Related]
7. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia.
Jha N; Seikaly H; Harris J; Williams D; Sultanem K; Hier M; Ghosh S; Black M; Butler J; Sutherland D; Kerr P; Barnaby P
Head Neck; 2009 Feb; 31(2):234-43. PubMed ID: 19107948
[TBL] [Abstract][Full Text] [Related]
8. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease--a prolonged study.
Nagler RM; Nagler A
Cancer Invest; 2003; 21(1):34-40. PubMed ID: 12643007
[TBL] [Abstract][Full Text] [Related]
9. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
Johnson JT; Ferretti GA; Nethery WJ; Valdez IH; Fox PC; Ng D; Muscoplat CC; Gallagher SC
N Engl J Med; 1993 Aug; 329(6):390-5. PubMed ID: 8326972
[TBL] [Abstract][Full Text] [Related]
10. Pilocarpine treatment in a mixed cohort of xerostomic patients.
Aframian DJ; Helcer M; Livni D; Robinson SD; Markitziu A; Nadler C
Oral Dis; 2007 Jan; 13(1):88-92. PubMed ID: 17241436
[TBL] [Abstract][Full Text] [Related]
11. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
12. Pilocarpine hydrochloride for symptomatic relief of xerostomia due to chronic graft-versus-host disease or total-body irradiation after bone-marrow transplantation for hematologic malignancies.
Singhal S; Powles R; Treleaven J; Rattenbury H; Mehta J
Leuk Lymphoma; 1997 Feb; 24(5-6):539-43. PubMed ID: 9086444
[TBL] [Abstract][Full Text] [Related]
13. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
14. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
[TBL] [Abstract][Full Text] [Related]
16. Oral pilocarpine hydrochloride for the treatment of refractory xerostomia associated with chronic graft-versus-host disease.
Singhal S; Mehta J; Rattenbury H; Treleaven J; Powles R
Blood; 1995 Feb; 85(4):1147-8. PubMed ID: 7849306
[No Abstract] [Full Text] [Related]
17. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients.
Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML
Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967
[TBL] [Abstract][Full Text] [Related]
18. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD).
Nagler R; Marmary Y; Krausz Y; Chisin R; Markitziu A; Nagler A
Bone Marrow Transplant; 1996 Feb; 17(2):219-24. PubMed ID: 8640170
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland involvement in graft-versus-host disease: the underlying mechanism and implicated treatment.
Nagler RM; Nagler A
Isr Med Assoc J; 2004 Mar; 6(3):167-72. PubMed ID: 15055275
[TBL] [Abstract][Full Text] [Related]
20. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
